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RThe surgical and interventional hybrid era: Experiences from ChinaEShengshou Hu, MD, MScIt was the best of times, it was the worst of times.we
had everything before us, we had nothing before us,
we were all going direct to Heaven, we were all going
direct the other way.
Charles Dickens, A Tale of Two Cities, 1859
It is estimated that more than 230 million Chinese have
some form of cardiovascular disease, and this number is pro-
jected to increase by 50% between 2010 and 2030.1 The
number of cardiac surgical procedures is therefore increas-
ing dramatically in China, with an annual volume of nearly
160,000 cases. Chinese cardiac surgeons, however, are con-
fronted by the same challenges as their Western counter-
parts. Catheter-based procedures were introduced in China
in the 1980s, along with the opening of New China. Driven
by patient demand andmarket forces, some procedureswere
quickly popularized across the country, and the traditional
open-chest surgical approaches gradually receded. The per-
cutaneous transcatheter aortic valve implantation procedure
has emerged as an attractive option for critically ill patients,2
and recently the first case of percutaneous transcatheter aor-
tic valve implantation was successfully performed by the in-
terventional cardiologists in Fuwai hospital in Beijing.
Although the current available evidence is inadequate to de-
termine the role of percutaneous transcatheter aortic valve
implantation in the treatment of heart valve disease, it is
a new challenge to surgical aortic valve replacement.
As a developing country, China has had an extremely
rapid pace of economic growth in the last 30 years. With
the ongoing improvement in the Medicare system, more pa-
tients can afford to undergo heart surgery, and the volume of
cardiac surgical procedures per program has steadily in-
creased 15% to 20% annually. Although many minimally
invasive technologies have been introduced and dissemi-
nated to the cardiac surgical community of China, less inva-
sive percutaneous interventional therapy is an attractive
option for many patients. The incomplete revascularization
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The Journal of Thoracic and Cardevice-related complications, however, remain problems
for interventional cardiologists. Therefore, the barriers be-
tween disciplines are being lowered, and a multidisciplinary
approach should be used when selecting the best therapy for
patients. In 1996, Angelini and associates3 combined the
techniques of percutaneous coronary intervention and min-
imally invasive direct coronary artery bypass grafting to
treat multivessel coronary artery disease. It was the first
time that a hybrid approach to integrate interventional and
surgical technology was used for patient care. During the
past decade, the hybrid approach has actually practiced
the principle of ‘‘Patients Always First’’ by providing
incremental benefits to patients with the best of combined
therapies.
With the development of devices and real-time imaging,
setting up a hybrid operating room to perform both surgery
and catheter-based therapy has become a reality. With the
aid of image-guided technology, surgeons can now use var-
ious interventional devices. Surgeons know more about the
anatomy, have no limits for access route, have operative
perception, and, most importantly, can use the traditional
surgical technology simultaneously. We have witnessed
the introduction of the hybrid concept and its booming de-
velopment across China. Now, more than 30 hybrid operat-
ing rooms are in clinical practice across China, and
surgeons from China have accomplished many successes
in the field of hybrid cardiac surgery, including procedures
in congenital heart disease, coronary artery bypass surgery,
and aortic surgery, as summarized in Table 1.4-10CORONARYARTERY DISEASE
Fuwai hospital has the largest cardiac surgical program in
China and all of Asia. As early as 1997, Dr Gao, the former
president of Chinese Association of Cardiology, and I
worked together to use videothoracoscopy-assisted mini-
mally invasive direct coronary artery bypass grafting and
angioplasty to treat multivessel coronary artery disease.11
The first hybrid experience by Chinese physicians was per-
formed sequentially between the catheter laboratory and the
traditional operating room. In 2007, the first true hybrid op-
erating room in China was established at Fuwai Hospital
and is now the hospital’s busiest operating room (Figure 1).
The past decade has brought developments in both percu-
taneous coronary intervention and coronary artery bypass
grafting. Both interventions have witnessed significant
technological advances, in particular the use of drug-
eluting stents in percutaneous coronary intervention and
increased use of arterial grafts in coronary artery bypass
grafting. The bifurcation lesion, total occlusion of the leftdiovascular Surgery c Volume 141, Number 6 1339
TABLE 1. Selected publications by Chinese surgeons in the field of
hybrid cardiac surgery
Reference Center Year Major topic
Zhang et al4 Fuwai 2007 Hybrid therapy for
neonatal PAIVS
Zhang et al5 Fuwai 2007 Peratrial pediatric ASD
device closure
Li et al6 Shanghai Chest 2008 VSD device closure
through lower
ministernotomy
Gang et al7 West China 2008 Open-chest perventricular
device closure of VSD
Xing et al8 Qingdao Children 2010 Multicenter trials for
perventricular VSD
device closure
Hu et al9 Fuwai 2010 Comparison of off-pump
coronary artery bypass
grafting with hybrid
coronary
revascularization
Chen et al10 Fujian Union 2010 Novel triple-branched
stent graft placement
technique for acute
type A aortic dissection
PAIVS, Pulmonary atresia and intact ventricular septum; VSD, ventricular septal
defect; ASD, atrial septal defect.
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Lanterior descending coronary artery, and left main coronary
artery disease, however, are still very challenging for cardi-
ologists. Because of the superb long-term patency of grafted
left internal thoracic artery, cardiologists perform the ‘‘pro-
tected’’ angioplasty after the surgeon has finished the left
internal thoracic artery–left anterior descending coronary
artery anastomosis. Encouraged by the initial hybrid expe-
riences, a new 1-stop strategy has been applied in Fuwai
Hospital for selected patients with coronary artery disease
since 2007. Now more than 104 patients have successfully
undergone this one-stop hybrid therapy.9 Because of anFIGURE 1. Distribution of various types of hybrid surgery in Fuwai hospital, B
hybrid operating room during the past 3 years. B, The distribution of these 3 disea
vessel disease; CHD, congenital heart disease.
1340 The Journal of Thoracic and Cardiovascular Suraging population and a higher incidence of coronary artery
disease, multivessel revascularization is increasing in
China. In a Chinese coronary artery disease database study
involving a total of 3720 patients, left main coronary, bifur-
cation lesion, and total occlusion of left anterior descending
coronary artery accounted for 20% of the coronary artery
disease seen in Chinese patients.12
CONGENITAL HEART DISEASE
Congenital heart disease is the leading birth defect in
China. Congenital heart disease accounts for more than
50% of surgical volume in most cardiac surgery programs
in China at Fuwai hospital, and more than 4500 patients
with congenital heart disease were operated on in 2010. In
our hybrid experiences for congenital heart disease, we
have developed a new hybrid approach for neonates with
pulmonary atresia with intact ventricular septum4 and
young children with atrial septal defect with partial anoma-
lous pulmonary venous connection. As of this writing, 30
neonates and infants with pulmonary atresia and intact ven-
tricular septum and favorable anatomy have undergone suc-
cessful open-chest perventricular balloon perforation and
valvuloplasty with or without modified Blalock–Taussig
shunt placement. We have also designed a new one-stop
strategy for tetralogy of Fallot and pulmonary atresia with
major aortopulmonary collateral arteries.13 Major aortopul-
monary collateral arteries were identified in 76% of the pa-
tients with tetralogy of Fallot or pulmonary atresia, and
82% of these underwent successful coil implantation. The
surgeons then opened the chest and started regular repair
immediately after the cardioangiography.
VASCULAR SURGERY
The hybrid operating room is the vascular surgeon’s fa-
vorite operating room. The concept of endovascular surgery
has expanded to the treatment of thoracic aortic aneurysmseijing, China. A, Numbers of cases of 3 major heart diseases treated in the
ses among the total 475 patients.CAD,Coronary artery disease;GVD, great
gery c June 2011
FIGURE 2. A proposed training program for the young hybrid cardiac
surgeon in China.
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Land aortic dissection. The number of cases of great vessel
disease repair performed in the hybrid operating room in
our center has increased dramatically during the past 3 years
(Figure 1). According to the 2005 Annual Report on Cardio-
vascular Disease in China,14 160 million people in China
have hypertension; the incidence of aortic dissection could
be as high as 20 to 50 per million population. With the aid of
the hybrid approach, the mortality and morbidity of aortic
surgery have been significantly reduced, and more patients
with great vessel disease will benefit from hybrid surgery at
their local centers in the near future.
CONCLUSIONS
Cardiac surgeons in China have many reasons to promote
hybrid surgery. First, they are not mere guests in the catheter
laboratory to assist the interventional cardiologist. Since the
catheter-based training programwas initiated for surgeons 5
years ago, surgeons have been free to use the devices and
play the lead in a hybrid procedure. Second, the high cost
of catheter-based therapy has often forced families to be re-
ferred to cardiac surgeons for their critically ill children
with congenital heart disease, and traditionally in China it
is the cardiac surgeon, not the pediatric cardiologist, who
first sees the patient with complex congenital heart disease.
Finally, a positive cycle among surgeons, cardiologists, and
local manufacturers has formed during the last 5 years. In
2008, the National Center for Cardiovascular Diseases
hosted the first International Symposium on Hybrid Ap-
proach to Heart Diseases. For the first time, international
and domestic surgeons and interventionalists discussed
the same case to choose the best therapeutic option for the
patient. More than 1000 local attendees were present, and
since then hybrid procedures have been a hot topic at every
major heart meeting in China.The Journal of Thoracic and CarSurgeonsmust experience the initial segment of a learning
curve to get acquainted with the new hybrid protocols and
with their new colleagues from the interventional commu-
nity. As a result, new training programs have begun to train
the new hybrid surgeon (Figure 2). The first young surgeons
from Fuwai Hospital have finished their overseas training in
a prestigious heart center in Western Europe, and since re-
turning to China they have passed their examinations and
are now licensed to perform interventional therapy.
Hybrid cardiac surgery has opened up a whole new per-
spective for the cardiac surgeon. It is time for us to make
the change. Surgeons should know and understand the de-
velopment of new interventional and hybrid technology,
and furthermore they should have the courage to leave their
own comfort zone. The success of hybrid surgery in China
indicates that a bright future lies ahead for our patients as
well as the cardiac surgical community.References
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